Boston Scientific Executive and Leadership Team

Daniel Brennan, the Executive Vice President & Chief Financial Officer at Boston Scientific, manages the global financial health and capital allocation strategies of the organization. This leadership role involves overseeing financial planning, reporting, and investor relations to ensure transparency and long-term value creation. By directing fiscal policy, Brennan supports the company's investment in research and development for minimally invasive technologies. The Executive Vice President & Chief Financial Officer monitors economic indicators to mitigate risks associated with global market fluctuations. Through strategic oversight of the MedSurg and Cardiovascular segments, Brennan ensures that financial resources align with operational priorities. This position requires close collaboration with the Board to maintain robust internal controls and financial integrity. Ultimately, Brennan drives the company's financial stability, enabling the continued commercialization of advanced medical devices that improve patient outcomes and clinical efficiency on a worldwide scale.

Bernardo Del, the Director, Finance (Country & Chief Financial Officer (Mexico) at Boston Scientific, oversees all financial operations and fiscal compliance within the Mexican market. This role involves managing regional budgets, tax strategies, and financial reporting to support the company's local commercial activities. By directing financial planning, Del ensures that resources are effectively allocated to support the distribution of minimally invasive medical devices. The Director, Finance (Country & Chief Financial Officer (Mexico) collaborates with regional leadership to optimize supply chain costs and improve operational efficiency. Through rigorous financial oversight, Del maintains the integrity of regional accounts while supporting growth initiatives. This position requires navigating complex regulatory environments to ensure sustainable business practices. Ultimately, Del secures the financial foundation for the company's operations in Mexico, enabling the delivery of advanced cardiac and interventional solutions to healthcare providers throughout the region.

Samuel Conaway, the President, Cardiology Sales, Chair of Close The Gap (US) at Boston Scientific, directs the commercial strategy and sales execution for the cardiology division within the United States. This role involves leading large-scale sales teams to expand the reach of cardiac devices and interventional technologies. By chairing the Close The Gap initiative, Conaway addresses healthcare disparities, ensuring that advanced medical solutions reach diverse patient populations. The President, Cardiology Sales, Chair of Close The Gap (US) collaborates with hospital systems to improve clinical efficiency and patient access to care. Through the implementation of targeted sales programs, Conaway drives revenue growth and market share expansion. This position requires deep understanding of the cardiovascular market and the ability to build strong relationships with healthcare providers. Ultimately, Conaway ensures that the company's life-saving technologies are effectively deployed to improve patient outcomes across the nation.

Joseph Bockover, the Manager, Area Business & Strategy Chief of Staff at Boston Scientific, directs operational workflows and strategic planning initiatives. This leadership role involves synthesizing complex data from the MedSurg and Cardiovascular segments to refine internal processes. By coordinating cross-functional teams, Bockover ensures alignment with corporate objectives regarding minimally invasive technology deployment. The Manager, Area Business & Strategy Chief of Staff facilitates communication between executive leadership and departmental heads to maintain organizational agility. Through rigorous analysis of market trends, Bockover supports the development of scalable business models that enhance clinical efficiency. This position requires constant monitoring of performance metrics to drive sustainable growth across diverse interventional specialties. Ultimately, Bockover optimizes resource allocation to bolster the company's competitive position in the global medical device landscape, ensuring that strategic goals translate into tangible improvements for healthcare providers and patients alike.

Deniz Özgünay, the Commercial Excellence Analyst and Chief of Staff - Growth Emerging Markets at Boston Scientific, architects data-driven strategies to expand market presence within high-growth regions. This role focuses on identifying untapped opportunities for minimally invasive technologies, ensuring that commercial operations align with regional healthcare demands. By analyzing sales performance and market penetration, Özgünay provides actionable insights that guide executive decision-making. The Commercial Excellence Analyst and Chief of Staff - Growth Emerging Markets coordinates with local teams to streamline distribution channels and improve product accessibility. Through the implementation of standardized commercial frameworks, Özgünay drives operational consistency across emerging markets. This leadership function involves evaluating competitive dynamics to maintain a strong foothold in evolving medical sectors. Ultimately, Özgünay secures long-term revenue growth by optimizing commercial strategies, ensuring that the company delivers advanced cardiac and interventional solutions to underserved patient populations worldwide.

Rafael Carbunaru, the Chief Technology Officer, Neuromodulation at Boston Scientific, directs the research and development of advanced neuro-interventional devices. This role involves overseeing the engineering lifecycle of complex cardiac and neurological systems, ensuring that every innovation meets rigorous clinical standards. By bridging the gap between technical feasibility and patient needs, Carbunaru drives the creation of next-generation catheters and implantable technologies. The Chief Technology Officer, Neuromodulation collaborates with clinical research teams to validate device efficacy and safety profiles. Through the management of intellectual property and technical roadmaps, Carbunaru maintains the company's leadership in minimally invasive medical solutions. This position requires deep expertise in bioengineering to solve intricate physiological challenges. Ultimately, Carbunaru accelerates the delivery of life-changing therapies to the market, ensuring that the company remains at the forefront of technological advancement in the global medical device industry.

Chan Ella, the Vascular Strategy Lead Chief of Staff at Boston Scientific, architects long-term growth plans for the vascular intervention portfolio. This role involves coordinating strategic initiatives that enhance the development and commercialization of stents and catheter-based solutions. By aligning departmental goals with the broader corporate mission, Ella ensures that vascular technologies reach healthcare providers efficiently. The Vascular Strategy Lead Chief of Staff facilitates cross-functional collaboration to address clinical challenges in cardiovascular care. Through the analysis of market dynamics and patient outcomes, Ella identifies opportunities for product innovation and portfolio expansion. This leadership function requires managing complex projects that span multiple interventional specialties. Ultimately, Ella drives the strategic direction of the vascular business, ensuring that the company maintains its commitment to providing advanced, minimally invasive solutions that significantly improve patient health and clinical performance across global markets.

Brian Dunkin, the Chief Medical Officer at Boston Scientific, directs the clinical strategy and medical affairs for the company's diverse portfolio of interventional technologies. This role involves providing expert guidance on the clinical application of catheters, stents, and cardiac devices to ensure optimal patient safety and efficacy. By engaging with the medical community, Dunkin fosters partnerships that drive the adoption of minimally invasive procedures. The Chief Medical Officer oversees clinical trials and evidence generation to support the commercialization of new medical solutions. Through the integration of clinical insights into product development, Dunkin ensures that all technologies address real-world healthcare needs. This leadership position requires maintaining high standards of medical ethics and scientific rigor. Ultimately, Dunkin influences the standard of care by championing innovative medical practices that improve patient outcomes and clinical efficiency across the global healthcare landscape.

Kenneth Stein, the Senior Vice President and Global Chief Medical Officer at Boston Scientific, directs the global medical strategy and clinical research initiatives for the entire organization. This role involves overseeing the safety and clinical performance of all minimally invasive technologies, from cardiac devices to complex surgical tools. By providing high-level medical leadership, Stein ensures that the company's innovations align with evolving clinical standards and patient needs. The Senior Vice President and Global Chief Medical Officer collaborates with regulatory bodies and healthcare institutions to validate the efficacy of new medical solutions. Through the management of global medical affairs, Stein fosters a culture of scientific excellence and patient-centered innovation. This position requires extensive expertise in clinical medicine to guide the development of life-saving therapies. Ultimately, Stein drives the company's global clinical impact, ensuring that advanced medical science translates into improved patient outcomes worldwide.

Brad Pulaski, the Regional Executive at Boston Scientific, directs operational activities and strategic growth within a designated geographic territory. This role involves overseeing the commercialization of minimally invasive technologies, ensuring that healthcare providers have access to the company's advanced cardiac and interventional solutions. By managing regional performance, Pulaski drives operational efficiency and market penetration. The Regional Executive coordinates with cross-functional teams to align local sales and marketing efforts with the company's global mission. Through the analysis of regional healthcare trends, Pulaski identifies opportunities to improve patient outcomes and clinical workflows. This leadership position requires strong management skills to navigate diverse market conditions and regulatory requirements. Ultimately, Pulaski secures the company's competitive advantage by fostering strong relationships with regional healthcare stakeholders, ensuring that the organization delivers high-quality medical devices that meet the specific needs of the local patient population.